Your browser doesn't support javascript.
loading
CNS Aspergillosis: A Downside of Corticosteroid Use.
Bonagiri, Pranay R; Raman, Anjalee; Hassan, Sharjeel; Ramsey, Andrea.
Afiliação
  • Bonagiri PR; Internal Medicine, Scripps Mercy Hospital, San Diego, USA.
  • Raman A; Internal Medicine, Touro University California, Vallejo, USA.
  • Hassan S; Internal Medicine, Scripps Mercy Hospital, San Diego, USA.
  • Ramsey A; Infectious Disease, Scripps Mercy Hospital, San Diego, USA.
Cureus ; 16(6): e62018, 2024 Jun.
Article em En | MEDLINE | ID: mdl-38984001
ABSTRACT
Glucocorticoids are ubiquitously used by physicians for a myriad of diseases. Though powerful and potentially lifesaving, sometimes the dangerous side effects are not at the forefront of our medical decision-making. By immunosuppressing patients, glucocorticoids can place patients at increased risk for not only the metabolic effects of chronic glucocorticoid use but also increased risk for opportunistic infections. Patients at increased risk include those on prolonged courses or those that require high doses. We report a case of a 34-year-old man who was initiated on glucocorticoids for an unknown rheumatologic disease and presented with generalized weakness, fatigue, nausea, and vomiting. The patient experienced a seizure, which prompted head imaging. A mass was found and eventually biopsied, which was notable for Aspergillus fumigatus. The patient was initiated on antifungals for CNS aspergillosis and recovered.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Cureus Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Cureus Ano de publicação: 2024 Tipo de documento: Article